Scientific discovery is driven by scientists generating novel hypotheses for complex problems that undergo rigorous experimental validation. To augment this process, we introduce Co-Scientist, a multi-agent AI system built on Gemini for structured scientific thinking and hypothesis generation. Co-Scientist aims to help scientists discover new original knowledge. Conditioned on their research objectives and prior scientific evidence, it formulates demonstrably novel research hypotheses for experimental verification. The system’s design involves agents continuously generating, critiquing and refining hypotheses accelerated by scaling test-time compute. Key contributions include: (1) a multi-agent architecture with an asynchronous task execution framework for flexible compute scaling; (2) a tournament evolution process for self-improving hypotheses generation. Automated evaluations show continued benefits of test-time compute scaling, improving hypothesis quality over time. While general purpose, we focus the validation in three biomedical applications: drug repurposing, novel target discovery 1, and explaining mechanisms of anti-microbial resistance 2. Specifically, Co-Scientist helped identify new drug repurposing candidates and synergistic combination therapies for acute myeloid leukemia, which were validated through in vitro experiments. These real-world validations demonstrate the potential of Co-Scientist to accelerate scientific discovery and usher in an era of AI empowered scientists.
Accelerating scientific discovery with Co-Scientist
Why This Matters
Co-Scientist represents a significant advancement in AI-powered scientific research, enabling faster and more efficient hypothesis generation and validation. Its multi-agent architecture and self-improving processes can accelerate discoveries across fields like biomedicine, ultimately benefiting researchers and consumers by speeding up the development of new treatments and solutions. This innovation highlights the transformative potential of AI in driving scientific progress and addressing complex challenges more rapidly.
Key Takeaways
- Multi-agent AI system enhances hypothesis generation and refinement.
- Test-time compute scaling improves the quality of scientific hypotheses.
- Validated in biomedical applications, including drug discovery and understanding antimicrobial resistance.
Explore topics:
co-scientist
gemini
drug repurposing
anti-microbial resistance
acute myeloid leukemia
Get alerts for these topics